Double immunolabeling with cytokeratin and smooth-muscle actin in confirming early invasive carcinoma of breast.
Double immunolabeling with cytokeratin and smooth-muscle actin in confirming early invasive carcinoma of breast. Am J Surg Pathol. 1999 Feb; 23(2):176-81.